Abbott India Ltd. Forms Death Cross, Signaling Potential Bearish Trend
Abbott India Ltd., a mid-cap pharmaceutical company, has recently encountered a Death Cross, indicating potential bearish market sentiment. The stock has underperformed against the Sensex over various time frames, and its P/E ratio is notably higher than the industry average, suggesting possible overvaluation amid challenging market conditions.
Abbott India Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has recently experienced a significant technical event known as a Death Cross. This occurs when a stock's short-term moving average crosses below its long-term moving average, often signaling a potential shift in market sentiment and a bearish trend.Today, Abbott India’s stock has shown a decline of 0.38%, contrasting with a positive performance of 0.44% from the Sensex. Over the past week, the stock has dropped by 1.89%, while the Sensex has gained 0.68%. This underperformance is further highlighted by a 14.54% decline over the past three months, compared to a 4.50% increase in the Sensex.
The current P/E ratio of Abbott India stands at 43.43, significantly higher than the industry average of 35.29, indicating that the stock may be overvalued relative to its peers. With a market capitalization of Rs 63,439.00 Cr, Abbott India’s performance metrics suggest a challenging environment, particularly as it grapples with bearish signals from technical indicators like MACD and moving averages. Investors will be closely monitoring these developments as they assess the stock's future trajectory.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
